DR. PARISA TARAVATI M.D.
Prescription History 1194933713
Ophthalmology in Seattle, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. PARISA TARAVATI M.D., an active Ophthalmology specialist practicing in Seattle, WA. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 700 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 235 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Latanoprost | 235 | $22.30▼ below WA avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 235 Medicare prescriptions for Latanoprost, about 2 times the volume of the typical Washington prescriber of this medication (120). Medicare paid an average of $22.30 per fill, versus $24.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 407 30-Day Fills standardized to 30-day supplies 11,859 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 99 | $61.37 | ≈ Typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 99 Medicare prescriptions for Prednisolone Acetate, about the same volume as the typical Washington prescriber of this medication (95). Medicare paid an average of $61.37 per fill, versus $48.29 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 124.9 30-Day Fills standardized to 30-day supplies 3,483 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 63 | $26.45 | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 63 Medicare prescriptions for Timolol Maleate, about the same volume as the typical Washington prescriber of this medication (61). Medicare paid an average of $26.45 per fill, versus $22.79 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 117.3 30-Day Fills standardized to 30-day supplies 3,446 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 59 | $15.70▼ below WA avg | ≈ Typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 59 Medicare prescriptions for Ofloxacin, about the same volume as the typical Washington prescriber of this medication (60). Medicare paid an average of $15.70 per fill, versus $18.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 59 30-Day Fills standardized to 30-day supplies 1,245 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 55 | $926.89▼ below WA avg | ▲ More than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 55 Medicare prescriptions for Restasis, about 1.3 times the volume of the typical Washington prescriber of this medication (41). Medicare paid an average of $926.89 per fill, versus $1,004.73 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 80 30-Day Fills standardized to 30-day supplies 2,385 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 45 | $940.42▼ below WA avg | ▲ More than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 45 Medicare prescriptions for Xiidra, about 1.7 times the volume of the typical Washington prescriber of this medication (26). Medicare paid an average of $940.42 per fill, versus $1,001.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 60 30-Day Fills standardized to 30-day supplies 1,800 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 44 | $44.91 | ≈ Typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 44 Medicare prescriptions for Brimonidine Tartrate, about 81% of the volume of the typical Washington prescriber of this medication (54). Medicare paid an average of $44.91 per fill, versus $34.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 72.5 30-Day Fills standardized to 30-day supplies 2,102 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 39 | $38.35 | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 39 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $38.35 per fill, versus $33.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 79.1 30-Day Fills standardized to 30-day supplies 2,373 Days of Medication total across all patients in 2023 | |||
| Ketorolac Tromethamine | 21 | $47.86 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2023, this provider wrote 21 Medicare prescriptions for Ketorolac Tromethamine, about a third of the volume of the typical Washington prescriber of this medication (68). Medicare paid an average of $47.86 per fill, versus $28.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.5 30-Day Fills standardized to 30-day supplies 712 Days of Medication total across all patients in 2023 | |||
| Dorzolamide Hcl | 14 | $34.96 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 14 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical Washington prescriber of this medication (39). Medicare paid an average of $34.96 per fill, versus $31.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.1 30-Day Fills standardized to 30-day supplies 753 Days of Medication total across all patients in 2023 | |||
| Cyclosporine | 13 | $368.27▼ below WA avg | ≈ Typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 13 Medicare prescriptions for Cyclosporine, about 76% of the volume of the typical Washington prescriber of this medication (17). Medicare paid an average of $368.27 per fill, versus $512.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 13 30-Day Fills standardized to 30-day supplies 375 Days of Medication total across all patients in 2023 | |||
| MoxifloxacinMoxifloxacin Hcl | 13 | $35.40 | ▼ Less than typical |
About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾ A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent. In 2023, this provider wrote 13 Medicare prescriptions for Moxifloxacin, about 18% of the volume of the typical Washington prescriber of this medication (73). Medicare paid an average of $35.40 per fill, versus $34.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 173 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. PARISA TARAVATI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Seattle, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among WA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
